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Abstract
Depression is a risk factor for the development of heart disease, as well as for
poor prognosis among patients with existing disease. However, clinical trials of treatment
of depression in patients with heart disease have not resulted in improved cardiac
outcomes, and have demonstrated modest effects on depression. The nature of depression
in heart patients must be better understood in order to improve treatment and health
outcomes. In samples of patients with medical illness as well as in patients with
depression, illness perceptions have been useful in predicting both treatment outcomes
and self-management behaviors such as coping and adherence. This is the first study to
examine patient perceptions of comorbid depression in heart disease. The purpose of the
study was to identify baseline correlates of illness perceptions in the context of a
depression treatment study. Results from 112 patients with comorbid depression and
heart disease, manifested as stable coronary heart disease or heart failure, show that
depression is strongly associated with perceived consequences, but that personality
factors are more strongly related to several other illness perception dimensions.
Depression history variables did not predict illness perceptions, but moderated the effect
of personality on timeline perceptions. Relationships among dimensions of illness
perceptions were somewhat consistent with findings from other study populations. This
study represents an important first step in clarifying how patients with heart disease
conceptualize comorbid depression. Future research is needed to determine if these
perceptions predict coping with depression, adherence to treatment, or treatment
outcomes.
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Patient Perceptions of Comorbid Depression in Heart Disease
Heart Disease and Depression
An important link between depression and the heart has been suspected by lay
persons for many centuries. It is common for individuals in intense psychological pain to
speak of experiencing a “broken heart” or “heartache.” However, it has only been in
recent decades that this purported link has been empirically investigated. Over the past 20
years, a robust literature has emerged showing depression to be not only a relatively
common problem in patients with various kinds of cardiovascular disease, but an
important prognostic indicator as well. Estimates of the prevalence of depression in heart
patients vary according to the method of assessment used and the particular patient
population under investigation. However, point prevalences have ranged from 14-47%
among patients with CAD (Lett et al., 2004). The diagnostic criteria for DSM-IV major
depressive disorder are met by an estimated 20% of patients after an acute myocardial
infarction (MI), with a similar percentage showing symptoms of mild depression
(Frasure-Smith et al., 1993; Hance, Carney, Freedland, & Skala, 1996). This percentage
decreases somewhat over time in the months following the MI as patients’ coronary
condition stabilizes. Patients hospitalized for heart failure (HF) are affected by depression
at comparable rates, with one study reporting 20% major depression and 16% minor
depression (Freedland et al., 2003). These rates correspond to a 3-4-fold increase
compared to prevalence estimates of depression in the general population (Rumsfeld &
Ho, 2005). When self-report depression questionnaires such as the Beck Depression
Inventory (BDI) are used, over 50% of cardiac patients score in the mild to clinically
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depressed range (Freedland et al., 2003). Psychologists and cardiologists alike are now
involved in efforts to improve recognition and treatment of depression in patients with
heart disease.
It is important for many reasons to treat depression in patients with cardiac
disease. Depression in its own right has a tremendous effect on both society and the
individual. It is recognized as a leading cause of disability world-wide, and is a major
cause of work place absenteeism, decreased productivity, and increased use of health care
resources (Murray & Lopez, 1996). Depression can lead to decreased quality of life,
hopelessness, and even suicide (Rumsfeld & Ho, 2005). In heart patients, depression is
associated with several additional adverse outcomes.
Depression has consistently been associated with increased morbidity and
mortality in patients with various manifestations of cardiac illness (Bush et al., 2005;
Carney et al., 1988; Connerney et al., 2001; Everson et al., 1998; Frasure-Smith et al.,
1993; Jiang et al., 2001; Whooley et al., 2008). Patients with existing heart disease who
are depressed are at increased risk for recurrent cardiovascular events, and have a two- to
four-fold increased risk of death after experiencing a cardiac event, with the greatest risk
occurring in the first six months after the event (Joynt, Whellan, & O’Conner, 2003).
Depressive symptoms, even in the absence of a diagnosable depressive episode, are
associated with an increased risk of cardiac events (Anda et al., 1993). Moreover,
evidence exists for a “dose-response” relationship, such that more severe depressive
symptoms pose a greater risk for future cardiac events (Anda et al, 1993; Pratt et al.,
1996). These relationships remain significant after controlling for potential confounding

2

factors such as age, gender, history and severity of heart disease, and risk factors such as
smoking, high blood pressure, body mass index, and socioeconomic status. Minor and
major depression increase the risk of rehospitalization and emergency department visits
after acute MI, thereby increasing health care costs (Reese et al., 2011). Depressed
cardiac patients also demonstrate more detrimental health behaviors than their
nondepressed counterparts. Patients with depression are significantly less likely to adhere
to lifestyle recommendations such as smoking cessation and exercise after experiencing a
cardiac event (Ziegelstein et al., 2000) and are less likely to adhere to their prescription
medication regimen (Gehi, Haas, Pipkin, & Whooley, 2005). Depression is associated
with decreased likelihood of attendance at, and less improvement in, cardiac
rehabilitation (Glazer, Emery, Frid, & Banyasz, 2002; Lane, Carroll, Ring, Beevers, &
Lip, 2001), and decreased likelihood of obtaining recommended medical tests (Rumsfled
& Ho, 2005).
For all the reasons stated above, the treatment of depression in heart patients is an
important endeavor. Additionally, when one considers the independent contribution of
depression to cardiac morbidity and mortality, it seems possible that treatment of
depression may be able to reduce at least some of its adverse effect on cardiac outcomes.
Relatively few large studies to date have investigated this question. The Sertraline
Antidepressant Heart Attack Trial (SADHART; Glassman et al., 2002) was a doubleblind, randomized, placebo-controlled trial designed to determine the safety and efficacy
of sertraline in depressed patients with a recent acute coronary syndrome (ACS).
Sertraline was found to be a safe medication in this population. Although the sample was
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not sufficiently large to study the effect of treatment on cardiac outcomes, there was a
trend toward decreased incidence of severe cardiac events in the treatment arm. The
SADHART study investigators recently conducted an analysis with sufficient statistical
power to model cardiac events occurring during the study’s seven year follow-up period
(Glassman, Bigger, & Gaffney, 2009). There was no difference in mortality between
individuals assigned to six months of sertraline treatment versus placebo. The original
SADHART report also examined the efficacy of sertraline therapy in treating depression.
There was no significant difference in Hamilton depression inventory scores (HAM-D;
Hamilton, 1960) between the sertraline and placebo groups. A significant improvement in
depression was observed in the subgroup of patients with severe, recurrent major
depression, although the treatment effect was modest (corresponding to about three points
on the HAM-D).
The Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD;
Berkman et al., 2003) study was a multicenter, randomized, controlled trial funded by the
National Heart, Lung, and Blood Institute (NHLBI), and was the first large trial in a
cardiac sample to test the effect of treating depression primarily with psychotherapy. It
was designed to assess whether treating depression after MI could reduce death and
recurrent nonfatal infarction. Low perceived social support (LPSS) was also a target of
treatment, due to its status as a risk factor for morbidity and mortality (Berkman, LeoSummers & Horwitz, 1992; Case, Moss, Case, McDermott, & Eberly, 1992). The 2481
participants were randomized to the treatment group or usual care (UC) within 28 days of
their MI. Treatment consisted of individual cognitive behavior therapy (CBT) augmented
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for a minority of participants by group therapy. Participants who were severely depressed
at enrollment or who did not show improvement after five weeks of CBT were also
treated with sertraline. Individual therapy continued until rigorous criteria for successful
treatment were met, or for a maximum of six months. Participants were followed up, and
any deaths or recurrent MIs were tracked, for an average of 29 months. Survival analyses
showed no significant difference between the treatment group and UC in the number of
recurrent MIs or deaths, or in the secondary medical endpoints. Similar to the SADHART
trial, ENRICHD analyses showed that treatment of depression was associated with
statistically significant but clinically modest improvement of depression.
Although the results of these two trials disappointed many researchers who had
hoped to demonstrate that treatment of depression could benefit cardiovascular prognosis,
the negative results have inspired much subsequent work. Interesting secondary analyses
have emerged out of both data sets, such as the 2008 report by Cowan et al., which found
that adherence to CBT homework assignments was the only consistent predictor of
improved depression in ENRICHD. Perhaps most important to advancing the field have
been the reflections on what could have been done differently in these trials. Sheps,
Freedland, Goldman, and McMahon (2003) suggest that, while the rationale for starting
treatment as early as possible seemed reasonable (since the highest risk of reinfarction or
death occurs within the first six months of the cardiac event), this likely resulted in the
inclusion of many transient cases of depression in the analyses – cases which would have
resolved quickly even without treatment. Indeed, recovery rates in the UC arm were high
(Berkman et al., 2003). Many researchers have also taken a step back after seeing these
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results, and concluded that perhaps these studies attempted to do too much, too soon.
Results of both studies indicated that not only were the treatments not associated with
improvement in measured cardiac outcomes, improvement of depressive symptoms was
modest. If the ultimate goal is to improve cardiac endpoints by treating depression, care
must be taken to develop maximally effective treatments for depression that occurs in the
context of cardiac problems.
The results of SADHART and ENRICHD suggest that there is room for
improvement in the methods used to treat depression in cardiac patients. In order to
improve treatment, we need to know more about the nature of depression in this
population. However, relatively few studies have examined psychological factors which
may be important for understanding depression in this population. No previous study has
examined cardiac patients’ perceptions of their depression and how these perceptions
may be related to depression severity, coping strategies, or treatment adherence, even
though these perceptions have been shown to relate to depression treatment in medically
well depressed patients.
The Common-Sense Model of Illness Representations
Theoretical model.

The Common Sense Model of Illness Representations

(CSM; Leventhal et al., 1980, Leventhal, Leventhal, & Breland, 2011) provides a useful
framework for conceptualizing how individuals formulate and organize beliefs about an
illness and how these beliefs influence behavior. This theoretical model, which has also
been referred to as the “Self Regulation Model,” emerged out of Leventhal’s work on
fear communication (Leventhal, 1970). The CSM states that individuals organize
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information about illnesses (both medical and psychiatric) into a cognitive representation
or model within an underlying processing system. These illness representations, or illness
perceptions, are influenced by factors such as one’s culture and prior experience with a
particular illness. Leventhal describes the individual as an active information-seeker and
problem-solver who, when confronted with a new sensation or experience (e.g., a
symptom), seeks to understand the experience and incorporate it into his/her cognitive
representation of that illness. He further characterizes this processing system as having
two parallel pathways in which separate cognitive (or objective) and emotional
representations exist for a given health threat. They are processed in a parallel but
relatively independent fashion. Additionally, representations can be either perceptual, as
in symptoms which are experienced (e.g., headache pain), or conceptual (e.g., an abstract
thought, such as “I must have a migraine”). These two levels may be at odds with one
another. For example, a person undergoing chemotherapy for cancer may conceptually
believe that the treatment will improve his or her cancer prognosis, while perceptually
(somatically), may feel much worse due to the treatment.
The content of illness representations can be organized into a number of
dimensions which have been empirically derived (Leventhal et al., 1980). Although other
dimensions have recently been added to the theoretical model, five primary dimensions
of illness representations have been supported by the literature, and therefore constitute
the “basic building blocks” of illness representations (Heijmans and de Ridder, 1998, p.
486). Illness identity is composed of the label an individual assigns to an illness and the
symptoms s/he associates with the illness. This is often measured by asking the individual
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to check on a symptom inventory all of the symptoms s/he has experienced as part of the
illness in question. The timeline dimension represents the individual’s beliefs about the
expected course of the illness—whether it will be acute or chronic, for example. The
consequences dimension is the extent to which the individual believes that the illness will
have significant effects on his/her life. An individual’s beliefs about what caused his/her
illness comprise the cause dimension. Causes are often grouped into categories such as
biological (e.g., germs or viruses), emotional/psychological (e.g., stress or personality),
and environmental (e.g., pollution or chemicals) (Hagger & Orbell, 2003). The fifth
major dimension is referred to as cure/control and represents the extent to which the
individual believes that his/her illness is amenable to cure or control by either medical
treatments or personal efforts. A factor analysis of one of the most common measures of
illness representations, showed that the cure/control items load onto two separate
factors—one related to personal control/self-efficacy, and the other related to perceived
treatment control/outcome expectancies (Moss-Morris et al., 2002). For this reason, the
cure/control dimension is often split into two separate dimensions of personal control and
treatment control. Illness representation dimensions are assessed either through openended interviews (Leventhal & Nerenz, 1985) or by self-report questionnaires such as
The Illness Perception Questionnaire (IPQ; Weinman, Petrie, Moss-Morris, & Horne,
1996), and The Revised Illness Perception Questionnaire (IPQ-R; Moss-Morris et al.,
2002). The latter are commonly used as they are relatively easy to administer and provide
quantitative measures of illness representation dimensions based on Likert scale ratings.
Several studies of the CSM dimensions have reported a consistent pattern of inter-
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relationships among the dimensions. This was confirmed by a meta-analysis of 45 studies
(Hagger & Orbell, 2003). Specifically, high scores on the identity dimension (indicating
that the individual experiences many symptoms associated with the illness) are related to
greater perceived consequences and a longer perceived timeline. Greater perceived
consequences are also associated with belief in a longer timeline. Higher scores on the
cure/control dimension (indicating a stronger belief that the illness is controllable) are
associated with fewer perceived consequences and a shorter perceived timeline. Finally,
higher illness identity scores are related to lower scores on cure/control. This consistency
in the inter-relationships of dimensions across samples lends support to the validity of the
CSM model as specified by Leventhal.
An important application of the CSM dimensions relates to their purported effects
on self-management behaviors such as coping. Leventhal posits that cognitive and
emotional representations are primary determinants of coping behavior, defined as the
procedures for preventing and controlling health threats (Leventhal, Nerenz, & Steele,
1984). Although Leventhal’s model does not specify exactly how CSM dimensions relate
to coping, this has been examined in numerous empirical investigations, and this work
will be reviewed shortly. While illness representations are thought to directly influence
coping behaviors, a feedback loop exists by which subsequent appraisal of the
effectiveness of coping can influence future coping strategies and, often, the very
definition or representation of the problem being defined or represented (Leventhal,
1984). Therefore, three stages of information processing influence coping behavior: 1)
the definition or representation of the problem; 2) planning and implementation of coping
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procedures; and 3) appraisal of the effectiveness of the coping procedure. Processing of
illness-related information proceeds to cycle through these three stages, with
effectiveness of current coping influencing future definitions of the problem as well as
future coping efforts.
It is through this process of influencing coping that illness representations are
thought to have an impact on illness outcomes. The CSM is therefore, in essence, a
mediational model (Brown et al., 2007; Hagger & Orbell, 2003) in which coping (or
health behavior) mediates the relationship between a person’s illness representations and
important functional outcomes. A major interest of researchers utilizing the CSM has
therefore been the investigation of relationships between CSM dimensions and illness
outcomes, and between CSM dimensions and coping.
Application of the Common-Sense Model to physical illness. Research on a
number of different medical populations has shown that illness representations are related
to coping behaviors as well as functional outcomes, including physical or emotional
functioning. Hagger and Orbell’s (2003) meta-analysis examined relationships among the
major CSM dimensions and various types of coping in a large sample of studies. The
studies included in the analysis involved 23 different illnesses, such as diabetes, chronic
fatigue syndrome, arthritis, and myocardial infarction. A number of significant
relationships were found between CSM dimensions and coping. Higher scores on the
cure/control dimension were associated with greater use of problem-focused coping,
cognitive reappraisal, and seeking social support. Higher scores on the consequences
dimension were related to greater avoidance, denial, and emotional expression, while
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higher scores on the timeline dimension were related to greater use of cognitive
reappraisal and modestly related to more avoidance and denial. This pattern suggests that
belief that an illness has serious consequences is associated with passive coping
behaviors, while belief in the controllability of the illness is associated with more active
and perhaps more adaptive coping.
Hagger and Orbell (2003) also examined relationships between CSM dimensions
and indicators of illness outcomes, and uncovered a number of patterns across illnesses.
The cure/control dimension was positively related to psychological well-being, social
functioning, and vitality, and was inversely related to distress and objective measures of
illness status (e.g., CD4 count for HIV status). Consequences and timeline were both
found to be inversely related to physical functioning, psychological well-being, role
functioning, social functioning, and vitality. These two dimensions were found to be
positively related to psychological distress. In other words, stronger beliefs in the
controllability of an illness are linked with positive outcomes such as well-being and
decreased distress. Conversely, stronger beliefs in the adverse consequences of an illness
are associated with poorer outcomes, such as decreased physical functioning and
decreased well-being, with the same pattern holding true for beliefs in a longer illness
timeline.
More recent studies have prospectively shown that “negative” perceptions of
illness (e.g., belief in a longer timeline, more consequences, and less controllability) are
related to negative outcomes, suggesting the predictive utility of the CSM framework.
Petrie et al. (1996) found that illness representations assessed during hospitalization for
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myocardial infarction (MI) predicted outcomes assessed three and nine months later.
Participants who perceived their illness as having less serious consequences were more
likely to return to work within three months. Patients who perceived their illness as being
more amenable to cure/control were more likely to attend cardiac rehabilitation.
Additionally, belief that the illness has serious consequences predicted disability at three
and six month follow-ups. In a sample of UK patients undergoing hemodialysis, illness
perceptions predicted all-cause mortality over a 16-month follow-up, even after adjusting
for known predictors of mortality in renal patients (Chilcot, Wellsted, & Farrington
2011). Galli et al. (2010) found that, in a sample of patients with chronic pain, illness
perceptions were strong predictors of disability, depression, and quality of life outcomes
measured after three and six months, adjusting for baseline pain and mood. A six-year
longitudinal study of patients with osteoarthritis found that changes toward more negative
illness perceptions were associated with increases in pain and functional disability, while
illness perceptions that became more positive over time were associated with improved
outcomes (Kaptein et al., 2010). Dickens et al. (2008) found that illness perceptions
predicted new onsets of depression in the first year of recovery from MI. Belief in a
longer timeline predicted new onsets of depression, while belief in the controllability of
heart disease was associated with a decreased risk of developing depression. Similar
prospective relationships have also been found in other illnesses, such as head and neck
cancer (Llewellyn, McGurk, & Weinman, 2007) and irritable bowel syndrome (Rutter &
Rutter, 2001), among others. Across prospective studies as well as the aforementioned
meta-analysis (Hagger & Orbell, 2003), certain dimensions of illness perceptions have
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been more consistently predictive of outcomes. Specifically, higher scores on the
dimensions of timeline and consequences are positively associated with poor outcomes,
while higher cure/control scores are positively associated with better outcomes.
One possible explanation for the relationship between negative illness perceptions
and negative outcomes could be that individuals who perceive more negative
consequences experience more negative outcomes because they have objectively worse
disease. Until recently, few studies had included in their models more objective measures
of disease state, making this a potential confound. However, several recent investigations
have found a significant effect for illness perceptions above and beyond the effect for
illness severity (e.g., Chilcot et al., 2011, Galli et al., 2010), suggesting that the
relationship between illness perceptions and health outcomes is not spurious. This
remains an important issue for future research nevertheless.
As the literature continues to build a strong case for the impact of illness
perceptions on coping behaviors and illness outcomes, only a few studies have tested
whether interventions to change maladaptive perceptions can improve outcomes. In a
randomized, controlled trial, Petrie, Cameron, Ellis, Buick, and Weinman (2002) showed
that a brief, in-hospital intervention was able to change the illness representations of MI
patients. Illness representations were measured at baseline and the intervention was then
individualized, based on each patient’s specific beliefs. The intervention attempted to
change illness representations toward being more adaptive, rather than simply being more
optimistic. For instance, participants who believed that their MI resulted in many
negative consequences often believed that they needed to decrease or discontinue many
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of their usual activities due to their heart disease. As a part of the intervention, such
beliefs were challenged and participants were given instruction with regard to what kinds
of activities are safe after MI. At discharge, patients demonstrated less negative beliefs
about the consequences, timeline, and controllability of their heart disease relative to their
beliefs assessed at hospital admission. At a three month follow-up, patients in the
intervention group were found to have returned to work sooner than the control group,
and they reported fewer symptoms of angina. Patients in the intervention arm were more
likely to report that they planned to attend cardiac rehabilitation, although actual
participation did not differ between the groups. Finally, participants in the intervention
group reported better understanding of their illness and better preparedness for hospital
discharge than those in the control group.
The same research team designed an innovative text message intervention
targeted at improving illness perceptions and adherence among patients with asthma
(Petrie, Perry, Broadbent, & Weinman, 2011). Patients who were randomized to the
intervention arm received via text message statements about asthma that were accurate
and encouraged self-efficacy. At 18 weeks, patients in the intervention arm reported
changes in illness perceptions that were more accurate (e.g., a chronic timeline) and more
adaptive (e.g., increased perceived personal control). Adherence to prescription inhalers
also improved.
Keogh et al. (2011) conducted a randomized trial of a two-session motivational
interviewing intervention designed to target negative or inaccurate illness perceptions
about type 2 diabetes, and to improve self-management of diabetes. Illness perceptions
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and hemoglobin A1C (an index of recent blood glucose levels) were measured at baseline
and six-month follow-up. Patients who received the intervention showed an increase in
their perception that diabetes can be controlled through their own efforts as well as
through medical treatments, and demonstrated statistically significant improvements in
their A1C.
Key features of the above studies appear to be the identification of illness
perceptions that might be problematic for successful self-management of illness, and the
delivery of an individualized intervention directly targeted at changing these perceptions.
These studies are encouraging as they suggest that maladaptive illness perceptions are
amenable to change through intervention, and that these changes are associated with
improved functional outcomes and self-management of illness. Cognitive therapy is a
particularly promising approach for changing inaccurate or overly negative illness
perceptions because it is designed specifically to modify maladaptive thoughts, beliefs,
and attitudes (Beck, Rush, Shaw, & Emery, 1979).
Application of the CSM to depression. Although the Common Sense Model is
purported to be applicable to mental disorders as well as to physical illness (Leventhal,
Diefenbach, & Leventhal, 1992), applications of the model to psychological phenomena
have lagged behind the physical illness literature. However, this has recently become an
active research area, and a growing number of studies are applying the CSM framework
to depression, in particular (e.g., Glattacker, Heyduck, & Meffert, 2012; Vollmann et al.,
2010). The results of these studies suggest that CSM dimensions are indeed useful for
predicting treatment adherence and outcomes in depression and other mental disorders.
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An important initial question is whether the same CSM dimensions operate in
mental and physical disorders. To investigate this, Fortune, Barrowclough, and Lobban
(2004) examined written descriptions of patients’ last depressive episode among a group
of currently or previously depressed women. Statements provided in the descriptions
were coded with respect to the five dimensions of the CSM. For example, an individual’s
statement that “I was so depressed I could not go to work for a month,” was categorized
as a “consequence” perception. Inter-rater reliability among the coders was high (0.82).
Few participants spontaneously wrote about all five dimensions of illness representations,
and most wrote about only two or three. This finding is consistent with previous work
done in physical illness (Lau, Bernard, & Hartman, 1989). The dimensions that were
most often written about were identity and consequences. The participants also completed
the IPQ (Weinman et al., 1996), and analyses revealed the same inter-relationships
among scales that have been found in the physical illness literature (described above),
lending further evidence to the utility of the CSM dimensions for the study of depression.
The authors concluded that patients’ “models of depression are similar in content and
structure to the models of physical ill health that have been identified in the Self
Regulation Model literature” (Fortune et al., 2004, p.357).
In one of the first papers to report on the application of the CSM to depression,
Brown et al. (2001) argue for the utility of the CSM in studying how patients manage
their depression and respond to treatment. The authors assert that depression is similar to
any other chronic illness for which self-management is important, and that illness
representations may be useful for understanding coping, help-seeking, and treatment
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adherence in depression. The authors examined illness representations in a sample of
depressed primary care patients and found that representations were related to past
treatment experience, coping strategies, and medication adherence. Specifically, patients
who had previously received treatment for depression perceived their disorder as having a
longer timeline, and as having greater consequences. Individuals who were currently
taking an antidepressant medication viewed their depression as having a longer timeline
than those who were not on medication. Although these results shed some light on the
ways in which an individual’s depression history may influence his or her cognitive
representation of current depression, they seem somewhat counterintuitive. To the extent
that treatment is efficacious, it should shorten the duration of depression and help to
minimize its adverse consequences, and yet individuals who had undergone treatment
perceived a longer timeline and more consequences. This is likely due to the fact that
individuals with more severe, protracted depressive episodes are more likely to get
treatment than patients with shorter, milder episodes. Similarly, individuals who are
taking antidepressant medication are more likely to have more severe depression than
those who are not taking medication. This question could be addressed by testing in a
multiple regression framework whether the current severity of depression is a better
predictor of illness representations than is past treatment for depression.
Research also suggests that illness perceptions may influence behaviors such as
coping and medication adherence in patients with depression. Brown et al. (2001) report
that, after adjusting for the severity of depression, illness perceptions were related to
coping strategies. Individuals who endorsed more adverse consequences of their
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depression tended to use active coping, religious coping, and self-blame. Patients who
perceived their depression as less controllable tended to use religious coping. Also,
participants who cited interpersonal factors as a cause of depression were less likely to
reliably take their antidepressants. The results of this study are somewhat inconsistent
with previously reported findings on the relationships between CSM dimensions and
coping in physical illness, which has found higher consequence scores to be associated
with less active coping and more avoidance. The authors note that their sample was quite
small, and that the study was intended as pilot work. A pattern more consistent with the
findings in physical illness emerged in a study by Kelly, Sereika, Battista, and Brown
(2007). Depressed patients who perceived more severe consequences of their depression
engaged in more maladaptive coping behaviors, such as rumination and engagement in
dangerous activities. More adaptive coping strategies such as positive reframing and
problem solving were endorsed by individuals who perceived greater control over their
depression. This pattern of results mirrors findings regarding illness representations and
coping in physical illness which have shown that higher scores on the consequences
dimension tend to be related to more maladaptive coping, while higher ratings of
cure/control are associated with more adaptive or active coping behaviors.
A German study recently reported on the utility of illness perceptions in
predicting depression treatment outcomes. Illness perceptions were assessed in a sample
of patients with depressive disorders, two weeks before they entered a 4-6 week inpatient
psychosomatic rehabilitation center (Glattacker et al., 2012). After accounting for known
predictors of depression, timeline and treatment control perceptions predicted depression
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severity and quality of life six months following treatment. However, the authors did not
investigate the mechanisms (e.g., adherence or coping) through which illness perceptions
influence depression outcomes.
Some research on patients’ beliefs about their depression has not specifically
employed the CSM model as a framework, but has used similar constructs. For example,
questionnaires that assess patients’ beliefs about medications would overlap with
treatment control perceptions. Russell and Kazantzis (2008) found that depressed patients
who reported more concerns about medication use were less likely to adhere to their
antidepressants. Increased concerns about medications may correspond to a lower score
on the CSM treatment control dimension. A corresponding decrease in adherence to
antidepressant medication would be consistent with the pattern that weaker beliefs in
cure/control are related to less adaptive coping behaviors (e.g., decreased adherence).
Other studies have also demonstrated that illness beliefs and beliefs about medications
are associated with adherence to antidepressant medications (Brown et al., 2005, and
Burra et al., 2007) as well as with reluctance to seek treatment (Edwards, Tinning,
Brown, Boradman, & Weinman, 2007).
Many investigations have focused exclusively on the cause dimension, often
referred to as “illness attribution.” A study by Lynch, Kendrick, Moore, Johnston, and
Smith (2006) found that patients with depression who believed their depression was
caused by genetic factors were less likely to adhere to their antidepressant medication
regimen. Perhaps a strong belief that depression is caused by genetic factors leads to an
erroneous conclusion that there is nothing one can do to alleviate this seemingly
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inevitable condition. Such pessimistic beliefs may lead to decreased motivation to adhere
to treatment regimens. Addis, Truax, and Jacobson (1995) have reported some intriguing
findings which suggest that particular kinds of attributions may be related to differential
performance across different types of therapy. Patients who attributed their depression to
existential causes (e.g., “I’m stuck where I am in life, nothing ever changes”) had better
therapy outcomes when assigned to cognitive therapy but worse outcomes when assigned
to behavioral therapy (Addis & Jacobson 1996). A different study found that cognitive
therapy was less effective in patients who made biological attributions for their
depression (Leykin, DeRubeis, Shelton, & Amsterdam, 2007). Schweizer et al. (2009)
examined how depression attributions related to treatment preference in a naturalistic
setting. Individuals with depression were informed about the treatment options available
to them at a mood disorders clinic (cognitive-behavioral therapy, interpersonal therapy,
or antidepressant medication [ADM]), and then chose their preferred treatment.
Participants who made intraindividual (e.g., characterological) attributions were more
likely to choose CBT, while those who made biological attributions were more likely to
choose ADM.
The CSM states that illness perceptions affect illness outcomes through behaviors
such as coping or adherence. A weakness of the literature on illness perceptions in
depression is the relative lack of longitudinal studies, which limits the conclusions that
can be drawn about how illness perceptions relate to coping, adherence, and depression
outcomes. Studies that have looked at illness perceptions and depression in a prospective
fashion have failed to report on hypothesized mechanisms of action. An ongoing study by

20

Brown and colleagues will examine coping behavior as a mediator of the relationship
between illness representations and psychosocial functioning in depressed primary care
patients over a one year period. Results from baseline data have been published and are
consistent with the possibility that individuals who perceive a longer timeline are more
likely to use strategies such as self-blame and behavioral disengagement, which leads to
lower psychosocial functioning (Brown et al., 2007). Although these are cross-sectional
findings, they raise the possibility that some of the effects of illness representations are
mediated by coping strategies. If this finding is confirmed in the longitudinal analysis, it
would be consistent with findings from the physical illness literature.
In summary, recent investigations applying the CSM to depression have found
that illness representation dimensions are linked to self-management behaviors such as
coping and adherence, as well as to depression outcomes (Brown et al., 2001; Kelly et al.,
2007; Brown et al., 2007; Glattacker et al., 2012). Related constructs, such as beliefs
about antidepressant medications (which correspond to the CSM dimension of
cure/control) predict adherence to prescribed medication regimens (Russell & Kazantzis,
2008). Beliefs in certain causes of depression may be related to antidepressant medication
adherence (Lynch et al., 2006), likelihood of successful outcomes across different
treatments (Addis & Jacobson, 1996; Leykin, et al., 2007), and treatment preferences
(Schweizer et al., 2009). Although the study of illness representations in depression is
still developing, it appears that these representations may be important for understanding
the process of recovery from depression. The proven utility of the CSM in predicting
important health behaviors and outcomes in physical illnesses also suggests the potential
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of this approach for characterizing comorbid depression in heart disease. The study of
illness representations in depressed cardiac patients may eventually inform treatments in
this population and help researchers develop more effective treatments—a necessary step
if the goal is to improve cardiovascular outcomes through alleviation of depression.
Personality, Heart Disease, Depression, and Illness Representations
Personality traits such as the five domains originally described by Costa and
McCrae

in

1992

(Extraversion,

Agreeableness,

Conscientiousness,

Emotional

Stability/Neuroticism, and Intellect/Openness) are related to coronary artery disease (e.g.,
Smith et al., 2008), depression (e.g., Trull & Sher, 1994), and perceptions of health and
illness (e.g., Goodwin & Engstrom, 2002). Moreover, personality disorders have been
shown to relate to these variables as well. The following is a brief review of the
personality literature relevant to this dissertation.
Personality traits such as neuroticism and hostility have been shown to be risk
factors for the development of coronary heart disease. For instance, Smith et al. (2008)
examined the relationship between spouse ratings of negative affectivity or neuroticism
facets, dimensions of the Interpersonal Circumplex (IPC), and coronary artery
calcification (CAC) in a sample of healthy older adults. The results showed that spouse
ratings of anger, anxiety, and depression were significantly related to CAC. Higher scores
on dominance and lower scores on affiliation were also related to CAC. There is also
evidence that personality pathology, particularly borderline personality disorder, is a risk
factor for cardiovascular disease (e.g., Moran et al., 2007).
Personality variables are related to mood states, including depression, in complex
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ways. Although a thorough review of this literature is outside the scope of this
dissertation, this section summarizes the key findings. Individuals with major depressive
disorder have been shown to score high on neuroticism, low on extraversion, high on
openness, and low on conscientiousness (Trull & Sher, 1994). Trait extraversion is
robustly correlated with positive affect (Watson & Clark, 1997). Personality pathology is
also related to depression in several important ways. First, there is a high rate of cooccurrence between major depressive disorder and personality disorders (e.g., Yen,
McDevitt-Murphy, & Shea, 2006). Comorbid personality disorders are associated with
increased distress, decreased functioning, a more difficult course, and poorer prognosis
(Skodol et al., 2005) among patients with major depressive disorder. Additionally, the
severity of personality pathology predicts recurrence of major depressive disorder
(Craighead, Sheets, Craighead, & Madsen, 2011). Finally, there is evidence for
differential treatment effects in patients with major depressive disorder and comorbid
personality disorder. Fournier et al. (2008) found that depressed individuals with
comorbid personality disorder responded less favorably to cognitive therapy than to
treatment with antidepressant medication, while individuals without personality disorder
showed a more positive response to cognitive therapy.
Leventhal’s Common Sense Model states that personality factors are likely to be
important determinants of illness representations and coping (Diefenbach & Leventhal,
1996). Previous research suggests a strong relationship between personality and
perceptions of health, although such perceptions have not typically been conceptualized
within a CSM framework. Much of this work has utilized measures of global

23

expectancies about health, such as optimism that one will remain healthy (Rasmussen et
al., 2006). Goodwin and Engstrom (2002) investigated the relationships between “big
five” personality traits and perceptions of health in a large community sample.
Participants were asked to rate their perceived health on a 5-point Likert scale ranging
from very poor to excellent. Among individuals with self-reported medical problems,
perceptions of good health were associated with high scores on Agreeableness, Openness,
Extroversion, Conscientiousness, and low scores on Neuroticism. Powers and Oltmanns
(in press) also found that more negative perceptions of health were related to neuroticism,
and additionally to three personality disorders (schizoid, antisocial, and borderline
personality disorder).
One of the few studies to examine the relationship between personality variables
and CSM-specified illness perceptions was conducted among a sample of patients who
had recently had a myocardial infarction (Williams, O’Connor, Grubb, & O’Carroll,
2011). Perceptions of heart disease were measured using the Brief Illness Perception
Questionnaire (BIPQ; Broadbent, Petrie, Main, & Weinman, 2006), and were examined
with respect to Type D personality, defined as the tendency toward negative affectivity
and social inhibition. Patients with Type D personality differed from patients without
Type D on all 7 dimensions of illness perceptions. Specifically, patients with Type D
perceived more adverse consequences, a longer timeline, less personal and treatment
control, lower illness coherence, higher emotional representation, and greater
symptomatology.
Goetzmann et al. (2005) conducted a cross-sectional examination of the “big five”
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personality factors (NEO-FFI; Costa & McCrae, 1992) and their relationships to illness
representations among lung transplant recipients. They found that individuals who
perceived having more control over their illness tended to have lower scores on
neuroticism and higher scores on openness to experiences.
Taken together, these findings suggest that personality variables influence patient
perceptions of health and illness. Personality is therefore important to take into account in
the context of the current study.
An additional consideration concerns the measurement of personality during a
depressive episode. Some researchers have warned that self-reports of personality
assessed during a depressive episode may be influenced by the depressive state
(Hirschfeld et al., 1983; Griens, Jonker, Spinhoven, & Blom, 2002), although others have
argued that this is not a serious concern (Bagby et al., 1998; Morey et al., 2010). Griens
et al. (2002) found that individuals with a depressive disorder reported levels of
neuroticism and extraversion which fluctuated with changes in depression severity over
12 weeks. The authors argue that their findings provide evidence that these personality
factors reflect states, and not traits, during a depressive episode. Although the change is
statistically significant, its clinical significance is questionable. Over the course of 12
weeks, extraversion and neuroticism scores on the NEO-FFI (Costa & McCrae, 1992a)
changed by only 1.6 and 3 points, respectively. Bagby et al. (1998) argue that the reports
of knowledgeable informants are less likely to be influenced by the patients’ depressive
mood state. They found that depressed patients’ ratings of their own personality on the
NEO PI-R (Costa & McCrae, 1992b) converged with ratings made by knowledgeable
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informants, suggesting that depressed mood may not unduly influence self-reported
personality traits. There is no consensus regarding the degree to which depressed mood
contaminates self-reported personality, so the potential effects of mood state should be
evaluated in future studies of the relationships among personality factors and illness
representations. Repeated administrations of self-report personality inventories will make
it possible to determine whether ratings vary with depressed mood state, and informant
ratings are believed to be less contaminated by the patient’s mood state. Finally,
participants should be instructed that when making ratings of personality, long-term,
stable characteristics should be considered over current emotional state (Griens et al.,
2002).
Research Goals
Recent work on depression in non-cardiac samples suggests that individuals’
beliefs about their depression are related to treatment outcomes (Addis & Jacobson,
1996; Leykin et al., 2007; Glattacker et al., 2012) as well as to coping strategies (Brown
et al., 2001, Kelly et al., 2007), adherence to pharmacological treatment (Brown et al.,
2001; Russell & Kazantzis, 2008), and treatment preferences (Schweizer et al., 2009).
Leventhal’s Common Sense Model of Illness Representations is the prevailing
framework for understanding these beliefs. The CSM states that individuals organize
their beliefs about an illness within a common-sense cognitive representation containing
a number of dimensions, including information about the illness’s cause, consequences,
timeline, perceived controllability, and associated symptoms (Leventhal et al., 1980).
These beliefs are proposed to be major determinants of coping behaviors, which in turn
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influence health and functional outcomes (Leventhal et al., 1984). Across a broad
literature, the most relevant illness perceptions appear to be consequences, cure/control,
and timeline. Higher ratings on the consequences and timeline dimensions consistently
relate to worse functional outcomes (e.g., physical functioning and emotional distress),
and often predict maladaptive coping. Conversely, the cure/control dimension appears to
be positively related to better outcomes (such as well-being and social functioning) and to
more adaptive or active coping procedures.
Given that illness representations are related to treatment, it is also important to
understand factors that relate to, or perhaps influence, CSM dimensions. Leventhal’s
Common Sense Model states that illness representations are determined by stable
characteristics such as personality traits, as well as past experiences with the illness in
question. However, very few studies have examined this. An additional problem with
many previous investigations of illness representations is the failure to account for the
potential confounding effect of illness severity. It is important to understand whether
illness representations are merely a reflection of the patient’s mood state or illness
severity. In other words, illness representations are expected to relate to these factors, but
not so strongly as to suggest they are measuring the same thing.
The purpose of this dissertation study is to examine cognitive representations of
depression (referred to as “illness perceptions”) in persons with depression and heart
disease. This is the first study to examine patients’ common-sense perceptions of
depression in a group of individuals with comorbid heart disease and depression. It is
designed to determine relationships among illness perception dimensions, depression
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severity, depression history, and personality traits in patients with comorbid depression
and heart disease, defined as either stable coronary heart disease or chronic heart failure.
As a primary aim, this study tested whether timeline, consequence, personal control, and
treatment control perceptions are influenced by more than just the severity of depression.
It was hypothesized that factors such as a patient’s previous experience with depression
as well as personality traits are uniquely related to CSM dimensions, after taking into
account depressive severity. A secondary aim of the study is to determine whether similar
patterns of relationships exist among the CSM dimensions in a depressed cardiac sample,
compared to the pattern which has been reported in medically-ill nondepressed patients,
as well as in depressed, medically-well populations. In future analyses, the relationship
between illness perceptions and depression treatment outcomes will be investigated.
Assessments were obtained at the baseline evaluation and the first intervention
session of a depression treatment study. The Illness Perception Questionnaire-Revised
(IPQ-R; Moss-Morris, 2002) was used to measure illness representation dimensions.
Analyses were performed at the subscale level, with subscales representing the illness
perception dimensions. The timeline, consequences, personal control, and treatment
control subscales were selected for analysis because these dimensions have shown the
most consistent pattern of relationships with coping and health outcomes in past research.
Primary Aims
Hypothesis 1. Individuals who view their depression as having many adverse
consequences are more severely depressed, have had more previous episodes of
depression, and are higher on neuroticism than individuals who report few adverse
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consequences. 1a) Depression severity is positively associated with adverse
consequences. 1b) Number of previous depressive episodes is positively related to
consequences independently of the severity of the current depressive episode. 1c)
Neuroticism is positively correlated with adverse consequences independently of the
severity of the current depressive episode.
These hypotheses are consistent with the cognitive model of depression, which
states that more severely depressed persons tend to hold more negative beliefs about the
future (Beck et al., 1979). It is also consistent with the Haggar and Orbell (2003) metaanalytic findings that, across a large number of studies, people who perceived greater
consequences of their illness reported higher emotional distress. Additionally, it is
plausible that individuals who have had more experience with (e.g., more episodes of)
depression have a higher probability of experiencing negative consequences in the past,
and therefore would perceive their depression as resulting in more negative
consequences. Finally, individuals who are high on trait neuroticism experience more
negative affectivity and may therefore be more likely to experience (and report) negative
consequences of their illness.
Hypothesis 2. Individuals who expect a longer (more chronic) timeline are more
severely depressed, have had longer past depressive episodes, and are higher on trait
neuroticism. 2a) More severe depression is associated with a longer perceived timeline.
2b) The experience of having longer previous depressive episodes is associated with a
longer perceived timeline for depression, independent of severity of current depression.
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2c) Neuroticism is positively correlated with timeline, independently of depressive
severity.
This hypothesis is again consistent with what is known about the cognitive
aspects of depression. Individuals who are more severely depressed tend to be more
pessimistic about the future, and are therefore expected to perceive a longer timeline for
their depression. In addition, a recent study by Freedland et al. (Freedland, Carney,
Steinmeyer, & Reese, 2010) found that ACS patients who were more severely depressed
following their cardiac event did indeed experience longer depressive episodes. This
hypothesis is also consistent with Hagger and Orbell’s (2003) meta-analysis which found
that a longer expected timeline was positively associated with distress across many
studies of various physical illnesses. It is also plausible that individuals who report
having had past episodes which were more protracted expect a longer timeline for their
depression. Finally, individuals who score higher on neuroticism tend to perceive poorer
health status (Goodwin & Engstrom, 2002), and are therefore predicted to expect a longer
timeline.
Hypothesis 3. Individuals who perceive more personal control over their
depression are less depressed, have lower levels of neuroticism, and higher levels of
conscientiousness than those who score low on personal control. 3a) Severity of
depression is inversely related to perceived personal control. 3b) Neuroticism is inversely
related to personal control, independent of depressive severity. 3c) Conscientiousness is
positively associated with personal control, independent of depressive severity.
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This hypothesis is consistent with meta-analytic findings in the illness
representation literature (Haggar & Orbell, 2003). Across numerous patient samples, the
cure/control scale (which has since been split into separate personal and treatment control
scales) was negatively associated with psychological distress. Goetzmann et al. (2005)
showed that lung transplant patients who perceived higher cure/control for their illness
scored lower on neuroticism.
Hypothesis 4. Participants who perceive their depression as being more amenable
to treatment control are less depressed, are more likely to have received previous
treatment for depression, and report lower levels of neuroticism. 4a) Depression severity
is inversely related to treatment control. 4b) Neuroticism is inversely related to treatment
control, independent of depressive severity. 4c) Previous treatment of depression is
associated with greater perceived treatment control, independent of depressive severity.
This hypothesis is consistent with meta-analytic findings in the illness
representation literature (Haggar & Orbell, 2003). Across numerous patient samples, the
cure/control scale was negatively associated with psychological distress. Additionally,
Goetzmann et al. (2005) showed that lung transplant patients who perceived higher
cure/control for their illness scored lower on neuroticism. Finally, it is expected that
individuals who perceive higher treatment control are more likely to have sought
treatment for depression in the past. Although Brown et al. (2001) found that individuals
who had previously received treatment for depression perceived more pessimistic illness
representations (longer timeline and perceived consequences), depressive severity was
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not included in their analyses. Therefore, it is expected that when depression severity is
accounted for, previous treatment should relate to reports of greater treatment control.
The aforementioned predictions state that individuals who are more severely
depressed hold more pessimistic beliefs about their illness. These hypotheses could also
be consistent with the possibility that more severe depression simply has worse
consequences, a longer timeline, and is less amenable to control, suggesting that patients’
perceptions are merely a reflection of the severity of their illness. If this study shows that
personality traits and past experience with depression are significantly related to illness
perceptions independent of depressive severity, this would suggest that illness
perceptions reflect more than just the severity of one’s depression.
Secondary Aims
Correlations among CSM dimensions were investigated to determine if the pattern
of interrelationships among illness representation domains is consistent with the pattern
found in nondepressed medically ill samples and medically-well depressed samples. It
was hypothesized that scales of the IPQ show interrelationships that are consistent with
both the physical illness literature (Hagger & Orbell 2003) and investigations of the IPQ
in depressed samples (Fortune et al., 2004). The following a priori hypotheses were
tested: Worse perceived consequences are associated with a longer expected timeline
(Hypothesis 5); greater perceived treatment control is associated with fewer perceived
adverse consequences (Hypothesis 6); greater perceived treatment control is associated
with a shorter expected illness timeline (Hypothesis 7); greater perceived personal control
is associated with fewer perceived adverse consequences (Hypothesis 8); and greater
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perceived personal control is associated with a shorter expected illness timeline
(Hypothesis 9).
Method
The hypotheses outlined above were tested in the context of two larger studies
conducted by Robert M. Carney, Ph.D. (Study A), and Kenneth E. Freedland, Ph.D.
(Study B). Only those aspects of the parent studies which are relevant to the current
analyses are described here.
Participants
A total of 112 participants (80 from Study A and 32 from Study B) were included
in the current study. All participants who completed at least the first intervention session
in Study A or B were included in the current analyses.
Study A included participants with major depressive disorder and stable CHD, all
of whom received treatment for depression. Participants met the DSM-IV criteria for a
current major depressive episode and scored 17 or higher on the 17-item Hamilton Rating
Scale for Depression (HAM-D-17; Hamilton, 1960) approximately 3 months after
hospitalization for an acute coronary syndrome (ACS). ACS was defined as the
occurrence of acute MI or unstable angina, evidenced by (1) symptoms of acute
myocardial ischemia in conjunction with (2) significant ST segment elevations or
depressions on electrocardiography (ECG) and/or (3) an elevation of serum troponin I
greater than 0.5 ng/ml. Patients were excluded from Study A for the following reasons: 1)
significant cognitive impairment as evidenced by a score equal to or greater than 20 on
the Short Blessed Test (SBT; Katzman et al., 1983); 2) severe Axis 1 comorbidities such
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as schizophrenia, bipolar disorder, active substance abuse, or alcoholism; 3) current use
of antidepressants; 4) severe medical conditions such as recurrent MI within 3 months of
the index event, severe congestive heart failure, malignancy, or serious physical
limitations; 5) exemption by the patient’s cardiologist or primary care physician; 6)
medical contraindications to the use of sertraline; 7) participation in a competing research
protocol; or 8) refusal to participate.
Study B included patients with depression and chronic heart failure (HF), who
were randomly assigned to a cognitive-behavioral intervention or to a usual care (UC)
control condition which did not provide any depression intervention. HF was evidenced
by 1) clinically diagnosed heart failure for at least three months prior to screening; 2) any
prior hospitalization with HF listed as a diagnosis; and 3) classification of New York
Heart Association (NYHA) class II or III. Participants met the following criteria for
depression: 1) DSM-IV criteria for a current major depressive episode, and 2) a score of
14 or higher on the Beck Depression Inventory (BDI-II; Beck, Steer, & Brown, 1996).
Patients were excluded for the following reasons: 1) exemption by the patient’s
physician; 2) dementia or significant cognitive impairment; 3) major mobility-limiting
physical disability; 4) poor one-year prognosis due to a condition other than heart failure;
5) logistical barriers to participation in laboratory visits; 6) less than 30 years of age; 7)
alcoholism or substance abuse, bipolar disorder, schizophrenia, or other psychotic
disorder; 8) high risk of suicide; 9) current nonstudy psychotherapy for depression or
other psychiatric problems; 10) initiation of antidepressant therapy in the past 8 weeks;
and 11) hospitalization for HF or ACS in the past month. In Study A, the decision was
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made to administer the current study’s primary measures at the first intervention session,
in order to minimize participant burden at the baseline visit (when a large battery of
assessments was already planned). To keep the procedures consistent, these measures
were also administered at the first intervention session in Study B. Therefore, the current
study includes only those Study B participants were who randomized to receive CBT.
Procedure
Study A recruitment. Participants for Study A were recruited from three St.
Louis area hospitals affiliated with Washington University School of Medicine and BJC
Healthcare. With the attending physician’s permission, patients admitted to the hospital
for ACS within the past 3 months were contacted about the study. Upon telephone
contact, patients were screened for depression by completing the Patient Health
Questionnaire (PHQ-9; Spitzer, Kroenke, & Williams, 1999). Patients who screened
positive for depression on the PHQ-9 were invited to visit the Behavioral Medicine
Center at Washington University School of Medicine, at which time study eligibility was
determined by administration of the BDI-II, the DISH depression interview (Freedland et
al., 2002), and HAM-D-17, as well as through a detailed medical history and physical
examination.
Study B recruitment. Study B recruited heart failure patients. Inpatients were
identified via systematic surveillance of admission lists at two area hospitals and were
contacted as described above for Study A. Outpatients were recruited from clinical
echocardiography services, heart failure clinics, general cardiology clinics, and
cardiology faculty group practices that are part of the BJC health care network. Study
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brochures were also placed at these sites, although few patients were enrolled through
this method. Eligibility was determined by telephone administration of the PHQ-9, as
well as a brief psychiatric history interview and screening form to assess for other
exclusion criteria. Patients who appeared eligible after the screening telephone call were
invited to attend a baseline evaluation appointment at the Behavioral Medicine Center.
Measures
Demographic Variables. Participants were asked to provide information about
their age, gender, race, ethnicity, education, income, and marital status.
Depression and Psychiatric History.
Beck Depression Inventory (BDI-II). The BDI-II (Beck, Steer, & Brown, 1996)
was used to assess self-reported depression symptoms. This 21-item measure is one of the
most widely used measures of depression severity, and has also been used extensively in
research on comorbid depression and heart disease. Participants were asked to rate the
severity of each symptom over the past two weeks, on a scale of 0-3. The total scale score
therefore ranges from 0-63. The coefficient alpha for the current study was 0.82.
Depression Interview and Structured Hamilton (DISH). The DISH (Freedland,
Skala, et al., 2002) was used to determine whether participants met the DSM-IV
diagnostic criteria for major depression. The instrument also yields the following
variables which were used in the current study: number of previous major depressive
episodes, length of the longest previous episode, and history of treatment for depression.
For the current study analyses, the field indicating length of the longest episode was left
blank for patients who had never had a previous episode. These patients were therefore
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not included in analyses of this variable. The DISH was recently recommended by an
NHLBI expert panel for the assessment and treatment of depression in patients with heart
disease (Davidson et al., 2006).
Beck Anxiety Inventory (BAI). The BAI (Beck & Steer, 1993) was used to assess
severity of self-reported anxiety symptoms. Participants were asked to rate the severity
of 21 symptoms over the past week, on a scale of 0-3. The total scale score therefore
ranges from 0-63.
Health Status and Medical History. Detailed information about participants’
medical history and current medical status were obtained from both hospital records and
from patient self-report. These data included information specific to cardiovascular health
(cardiovascular history, cardiological test data, history of revascularization, and cardiac
risk factors) and information about any other major medical illnesses (past or current), as
well as current medication use.
Personality traits. The short form of the International Personality Item Pool
(Mini-IPIP) was used to assess the Big Five factors of personality: Extraversion,
Agreeableness, Conscientiousness, Neuroticism, and Intellect/Imagination (sometimes
referred to as Openness) (Donnellan, Oswald, Baird, & Lucas, 2006). This 20-item
measure uses four items to assess each big five trait. It was designed as a short form of
the 50-item International Personality Item Pool—Five-Factor Model measure (IPIP-FFM;
Goldberg, 1999), which is available in the public domain. Because the participants were
both medically ill and depressed, the short form was used in order to minimize participant
burden. The Mini-IPIP includes statements describing personality characteristics, such as
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“I am the life of the party,” and “I do not have a good imagination.” Participants were
asked to indicate the accuracy of each statement on a 5-point Likert scale ranging from 1
(very inaccurate) to 5 (very accurate). Scores were then summed for each factor. Internal
consistency reliabilities for each of the five scales have been shown to be well above .60
in a series of five studies conducted by the scale developers. The largest study, which
included a sample of over 2500 adults, reported the following coefficient alphas:
extraversion = .77; agreeableness = .70; conscientiousness = .69; neuroticism = .68; and
intellect/imagination = .65. In the same study, convergent correlations were high between
the Mini-IPIP scales and Goldberg’s IPIP-FFM scales (r = .93 for extraversion, .89 for
agreeableness,

.90

for

conscientiousness,

.92

for

neuroticism,

and

.85

for

intellect/imagination). The coefficient alphas for the current study are provided in Table
1. Alpha values for the Mini-IPIP ranged between .63 and .67, with the exception of
neuroticism (.49).
Illness Representations. The Revised Illness Perception Questionnaire (IPQ-R;
Moss-Morris et al., 2002) was used to assess participants’ cognitive representations of
their depression. The IPQ-R and the original version of the instrument, the IPQ
(Weinman, et al., 1996), were designed to measure the illness representation domains
described in Leventhal’s common-sense model of illness representations (Leventhal et
al., 1984). Specifically, the IPQ was composed of 5 subscales, corresponding to
Leventhal’s domains of illness representations: identity, consequences, cure/control,
cause, and timeline. Since its development, the IPQ has been widely used as a measure of
illness representations in many chronic diseases, including heart disease (Petrie et al.,
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1996; Aalto, Heijmans, Weinman, & Aro, 2005; Dickens et al., 2008). It has also been
shown to relate to a number of constructs as proposed by the CSM, including coping
(Heijmans & deRidder, 1998), mood (Grace et al., 2005; Hermele, Olivo, Namerow, &
Oz, 2007), and adherence (Cooper, Lloyd, Weinman, & Jackson, 1999; Weinman, Petrie,
Sharpe, & Walker, 2000).
Revision of the IPQ was undertaken due to concerns about some of the subscales’
psychometric properties (Moss-Morris et al., 2002). In particular, the cure/control and
timeline scales lacked internal consistency. When cure/control was reanalyzed using
factor analysis, it was discovered that items loaded onto two separate factors—one
related to personal control/self-efficacy, and the other related to perceived treatment
control/outcome expectancies. Since these two factors were only weakly correlated, two
separate subscales were created. Concerns about the internal consistency of the timeline
scale were remedied by increasing the number of items on that scale, and by adding an
additional subscale assessing cyclical timeline beliefs. The authors also added a subscale
to assess emotional representations of illness, in order to more completely reflect the
parallel processing of both cognitive and emotional representations described in the
CSM. Finally, the authors added another subscale to assess “the extent to which a
patient’s illness representations provided a coherent understanding of the illness” (MossMorris et al., 2002, p. 2). Including both the new subscales and the original five domains
of the IPQ, the IPQ-R contains the following 9 subscales: identity, consequences, cause,
personal control, treatment control, timeline (acute/chronic), timeline cyclical, emotional
representations, and illness coherence.
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Sections of the IPQ-R which were administered in the current study included all
scales except the identity and cause scales. The list of symptoms which comprises the
IPQ-R identity scale includes experiences typical of physical illness, such as sore throat,
nausea, breathlessness, and stiff joints. These symptoms are not necessarily applicable to
depression. Similarly, the cause scale includes items that are unlikely to be endorsed as
causes of a depressive disorder, such as “a germ or virus,” “diet or eating habits,” and
“pollution in the environment.” In order to include either of these scales, lengthy
modifications would have been necessary to make the scales more applicable to
depression. For these reasons and in order to decrease participant burden, the identity and
the cause subscales were excluded from the current study. Participants were administered
the free-response causal item, which asks participants to rank the three most important
factors they believe to have caused their illness (depression). The IPQ-R was also
modified to read “your depression” instead of “your illness,” as has been done in other
studies using the IPQ-R in depression (Fortune et al., 2004; Glattacker et al., 2012;
Vollmann et al., 2010). It is also recommended in the scoring materials for the IPQ-R that
the word “illness” be replaced with the name of the specific illness under study (MossMorris et al., 2002).
The IPQ-R asks participants to read various statements about their illness and rate
their agreement with each statement on a Likert scale with the following responses:
strongly disagree, disagree, neither agree nor disagree, agree, and strongly agree. Each
rating has a corresponding numerical value. IPQ-R scale scores are then obtained by
summing the values for the items on each scale. Higher scores on the timeline,
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consequences, timeline cyclical, and emotional representation scales have a negative
valence, indicating beliefs that the illness will have a long timeline, more negative
consequences, a more cyclical nature, and a greater emotional impact. High scores on the
personal control, treatment control, and coherence scales have a positive valence,
representing beliefs that the illness is amenable to control by personal efforts or
treatment, and a greater personal understanding of the condition.
Psychometric data on the IPQ-R are reported in the original paper (Moss-Morris
et al., 2002). The seven subscales used in the current study demonstrated good internal
consistency on a sample of 711 patients from 8 different illness groups, with Cronbach
alphas ranging from .79 to .89 (Moss-Morris et al., 2002). In addition, the 38 items
corresponding to these seven scales were entered into a principal components analysis,
which produced seven factors corresponding to the theoretically derived scales. As
described above, inter-relationships among the various scales have also indicated logical
relationships. For example, high scores on the control subscale correlate negatively with
more pessimistic illness representations in other domains, such as the belief in a long
timeline or in serious consequences (Moss-Morris, 2002). The IPQ-R has shown
reasonably good test-retest reliability, with correlations ranging from .46 to .88 over a
three-week period in renal dialysis patients. The six-month stability in the same sample
showed correlations all greater than .5 (Moss-Morris, 2002). In order to demonstrate that
the IPQ-R measures more than simply affective states, the scale developers report small
to moderate correlations between IPQ-R dimensions and the PANAS (Watson, Clark, &
Tellegen, 1988). The largest correlation reported was .54, which was found between
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emotional representations and negative affect.
The IPQ-R has also been shown to have acceptable psychometric properties when
used to examine illness perceptions of depression (Glattacker et al., 2012). Internal
consistency of the timeline, consequences, and cure/control scales ranged from .56 to .76,
and two-week test-retest reliability was .68 or above for each scale. In addition, the
pattern of correlations among subscales in depressed samples resembles the pattern seen
in studies of IPQ dimensions in physically ill patient populations (Fortune et al., 2004).
Table 1 displays the coefficient alphas for the current study, which vary between .71 and
.82, with the exception of the timeline cyclical scale (.57).
Two studies by Brown et al. lend evidence to the validity of the IPQ as a measure
of depressed patients’ cognitive models of depression. Brown et al. (2001) found that
after accounting for severity of depression, illness cognitions in depressed primary care
patients were associated with current and past treatment-seeking behavior, medication
adherence, and coping strategies. Kelly et al., (2007) also found that illness representation
dimensions were related to coping in a depressed sample, and the results paralleled
findings regarding illness representations and coping in physical illness. Finally, Brown
et al. (2007) found evidence that maladaptive coping strategies played a mediational role
in explaining the relationship between illness representations and psychosocial wellbeing. The latter finding is consistent with Leventhal’s (1984) full Common-Sense
Model, which states that illness representations influence coping strategies and health
behaviors, which in turn influence health outcomes.
Timeline for assessments.

The BDI-II and the DISH were administered at
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baseline. The IPQ-R and the Mini-IPIP were administered to participants in both studies
at the first intervention session. All other data used in the current study (such as
demographic information and medical history) were collected at baseline.
Statistical Analysis
A Priori Hypotheses.
Hypothesis 1. 1a) Depression severity is positively associated with adverse
consequences. 1b) Number of previous depressive episodes is positively related to
consequences independent of the severity of the current depressive episode. 1c)
Neuroticism is positively correlated with adverse consequences independently of the
severity of the current depressive episode. To test these hypotheses, a hierarchical linear
regression analysis was conducted with severity of depression (measured by the BDI-II)
entered in the first step, number of previous episodes of depression entered in the second
step, and Mini-IPIP neuroticism score entered in the third step. It was hypothesized that
all predictors would be significant in the complete model, suggesting that personality and
experience have independent explanatory power above and beyond the severity of
depression.
Hypothesis 2. More severe depression is associated with a longer perceived
timeline. 2b) The experience of having longer previous depressive episodes is associated
with a longer perceived timeline for depression, independent of severity of current
depression. 2c) Neuroticism is positively correlated with timeline, independently of
depressive severity. To test these hypotheses, a hierarchical linear regression analysis was
conducted with BDI entered in the first step, length (in weeks) of the longest previous
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depressive episode entered in the second step, and Mini-IPIP neuroticism entered in the
final step. It was predicted that all variables would be significant in the complete model,
indicating that personality and experience help to explain expected timeline, after
accounting for depression severity.
Hypothesis 3.

3a) Severity of depression is inversely related to perceived

personal control. 3b) Neuroticism is inversely related to personal control, independent of
depressive severity. 3c) Conscientiousness is positively associated with personal control,
independent of depressive severity. To test these hypotheses, a hierarchical regression
analysis was conducted with BDI entered as the first predictor, followed by the Mini-IPIP
neuroticism and conscientiousness scores. It was hypothesized that all predictors would
be significant in the complete model, suggesting that neuroticism and conscientiousness
help to explain perceived personal control, after adjusting for the effect of depression
severity.
Hypothesis 4. 4a) Depression severity is inversely related to treatment control.
4b) Neuroticism is inversely related to treatment control, independent of depressive
severity. 4c) Previous treatment of depression is associated with greater perceived
treatment control, independent of depressive severity.

To test these hypotheses, a

hierarchical regression analysis was conducted with BDI entered as the first predictor,
followed by Mini-IPIP Neuroticism score.

In the last step of the model, a binary

indicator of the presence or absence of past treatment for depression was entered. It was
expected that all predictors would be significant in the complete model, indicating that
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neuroticism and past experience with treatment helps to explain perceived treatment
control, after adjusting for the effect of depression severity.
Hypotheses 5-9. 5) Worse perceived consequences are associated with a longer
expected timeline, 6) greater perceived treatment control is associated with fewer
perceived adverse consequences, 7) greater perceived treatment control is associated with
a shorter expected illness timeline, 8) greater perceived personal control is associated
with fewer perceived adverse consequences, and 9) greater perceived personal control is
associated with a shorter expected illness timeline. To test these hypotheses, bivariate
correlations were calculated between scores on each relevant pair of IPQ-R scales.
Exploratory analyses.
Relationships among Big Five personality traits, depression severity, and all seven
illness representation dimensions were explored in correlational analyses. Depression was
expected to relate modestly, if at all, with illness perception dimensions. In other words,
depression scores were expected to relate to illness perception scores, but not so strongly
as to suggest they are measuring the same construct.
Tests of statistical assumptions. For the primary analyses (hypotheses 1-4), data
were examined for violations of statistical assumptions. Scatter plots were examined for
evidence of linearity in the relationships between predictors and outcomes. Scatter plots
were also used to examine outliers. Dependent variables (IPQ-R consequences, timeline,
personal control, and treatment control) were tested for skewness and kurtosis.
Distributions of regression residuals were compared to the normal distribution. To test for
homoscedasticity of errors, plots of predicted values versus residuals were examined.
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The assumption of independence of errors was examined using the Durbin-Watson
statistic. Finally, tests for multicollinearity of predictors were conducted. No evidence
was found for skewness or kurtosis in the distributions of the four primary dependent
variables (IPQ-R consequences, timeline, personal control, and treatment control). Scatter
plots of each predictor versus dependent variable were examined for outliers. One major
outlier was found on the duration of longest episode variable (included in Hypothesis 2).
This value was removed and the regression analysis was re-run, with no change in results.
The results reported here therefore include this observation. Scatter plots were then
examined with respect to the linearity of the relationships between predictors and
outcomes. No evidence was found for nonlinear relationships. For each regression
analysis, a histogram of residuals was compared to a normal distribution curve and
normal probability plots were examined. All residual distributions were approximately
normal, consistent with multivariate linear regression assumptions. To test for
homoscedasticity of the errors, plots of predicted values versus residuals were examined.
Scatter plots revealed no evidence for heteroscedasticity. The assumption of
independence of errors was examined for each analysis using the Durbin-Watson statistic.
The computed statistic did not indicate a violation of this assumption. Finally, tests for
multicollinearity of predictors were conducted. Tolerance and VIF statistics were
computed and did not indicate any significant multicollinearity issues.
Results
Descriptive Statistics
Demographic variables. A total of 112 patients were enrolled in the study,
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including 80 patients (71%) from Study A, and 32 (29%) from Study B. Table 2 displays
demographic and medical characteristics of the sample. The complete sample includes 45
women (40%) and 67 men (60%). The participants ranged in age from 30 to 81, with a
mean (SD) age of 59 (10.3) years. The sample was 79% white (N=88) and 20% AfricanAmerican (N=23). Thirty-one percent of the participants (N=28%) reported having a high
school education or less, while 72% (N=81) had more than a high school education.
Depression, personality, and illness perceptions.

Table 3 describes the

psychological variables. Baseline BDI scores ranged from 16 to 51, with a mean score of
30 (8). As part of the DISH, patients were asked whether they had ever experienced a
depressive episode prior to the current one, and if they ever received treatment for
depression. Those who reported having a previous episode were asked how many
episodes they had, when they occurred, and how many weeks the longest episode had
lasted. Eighty-one percent of patients (N=91) reported having a previous depressive
episode, and over two thirds of the sample (71%; N=80) stated that they had previously
received treatment for depression. Among the 91 patients who reported having had a
previous episode of depression, the average number of reported episodes was
approximately 3 (2.6), while the modal number of episodes was 1 (32%). The mean
reported duration of the longest depressive episode was 82 weeks (123; range: 2-884).
The average age at first episode was 32 years (16), while age at last episode was 48 (14).
The average number of days between baseline assessment and initial CBT session was
11.4 (7).
Primary Analyses
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Hypothesis 1. The results of the regression analysis are presented in Table 4. 1a)
The BDI accounted for a significant amount (15%) of the variance in IPQ-R
consequences in the first step of the model (p < .001). 1b). The model was not
significantly improved by adding neuroticism in step two of the model. 1c) The model
was also not improved by adding number of depressive episodes in step three. All twoway interactions were tested, and none were found to be significant.
Hypothesis 2. Table 5 displays the results of the regression model predicting
IPQ-R timeline. 2a) The BDI accounted for 6% of the variance in timeline in the first step
of the model (p < .05). 2b) Neuroticism accounted for an additional 10% of the variance
in timeline when it was added in the second step of the model (p < .01). With neuroticism
in the model, BDI was no longer significantly related to timeline (p = .40). 2c) The
addition of the duration of longest depressive episode variable did not account for a
significant additional proportion of variance in the third step of the model. The only
significant regression coefficient in the full model was neuroticism (p < .01). All twoway interactions were tested. A significant interaction was found between neuroticism
and duration of longest depressive episode (p < .05). To examine the nature of the
interaction, the duration variable was divided into three groups: short duration (less than
or equal to 6 months), medium duration (greater than 6 months but less than two years),
and long duration (greater than or equal to two years), and the relationship between
neuroticism and IPQ-R timeline was plotted for each group. As can be seen in Figure 1,
the relationship between neuroticism and timeline decreases as a function of increasing
depressive episode duration (r = .59 for short, r = .41 for medium, and r = .12 for long).
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Hypothesis 3. Results of the personal control regression analysis can be found in
Table 6. 3a) BDI did not account for a significant portion of variance in step 1 of the
model. 3b) Neuroticism did not significantly relate to personal control. 3c)
Conscientiousness did not significantly relate to personal control. The full model
accounted for only 4% of the variance in personal control. All two-way interactions were
tested, and none were found to be significant.
Hypothesis 4. Results of the regression analysis for treatment control can be
found in Table 7. 4a) The BDI did not account for a significant proportion of the variance
in IPQ-R treatment control in the first step of the model. 4b) The addition of neuroticism
accounted for a significant proportion of variance (6%) in step two (p < .01). 4c) Past
treatment of depression in step three did not account for a significant portion of the
variance in the outcome. In the full regression model, neuroticism remained the only
variable significantly (negatively) related to treatment control (p < .01). Two-way
interactions were tested, and none were found to be significant.
Secondary Analyses
Hypotheses 5-9. The bivariate correlations between scales of the IPQ-R can be
found in Table 8. As predicted, higher scores on the consequences scale were
significantly associated with higher scores on the timeline scale (r = .263, p = .005).
Treatment control was not correlated with the consequences scale (p = .919), but higher
scores on treatment control were associated with lower scores on the timeline scale (r = .41, p < .001). The personal control scale was not related to the IPQ-R consequences
scale (p = .66), but was significantly negatively associated with the IPQ-R timeline scale
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(r = -.47, p < .001).
Exploratory analyses
Pearson correlations were calculated to explore relationships between illness
perceptions and mood, depression history, and personality.
Relationships between IPQ-R scales and mood. Table 9 displays results for
bivariate correlations between IPQ-R scales and mood. In Pearson correlations, BDI was
significantly positively associated with three of the IPQ-R scales: consequences (r = .38,
p < .001), timeline (r = .24, p = .01), and emotional representation (r = .53, p < .001).
Anxiety (measured by the BAI) was significantly related to the emotional representation
scale (r = .37, p < .001). To determine if this relationship could be accounted for by
neuroticism, a multiple regression analysis was conducted. In the model, both BAI and
neuroticism were significantly related to emotional representation (both p <.01).
Relationships among IPQ-R scales. Bivariate correlations among IPQ-R scales
can be found in Table 8. In addition to the hypothesized relationships described above,
significant bivariate relationships were also found between IPQ-R personal control and
the treatment control (r = .57, p < .001), between emotional representations and
consequences (r = .58, p < .001), and between emotional representations and timeline (r
= .32, p = .001).
Relationships between IPQ-R scales and personality. Bivariate correlations
between IPQ-R scales and Personality can be found in Table 10. Among Mini-IPIP
scales, neuroticism was correlated with five of the seven IPQ-R scales. In Pearson
correlations, neuroticism was significantly related to consequences (r = .30, p = .001),
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timeline (r =.39, p < .001), personal control (r = -.19, p = .040), treatment control (r = .22, p = .020), and emotional representations (r = .49, p < .001). Conscientiousness was
related to consequences (r = .28, p < .01) and emotional representation (r = .26, p < .01).
Openness was significantly associated with illness coherence (r = .33, p < .001).
Agreeableness was related to personal control (r = .26, p < .01), and extraversion was
related to timeline (r = -.25, p < .01). Regression analyses from Hypothesis 2 (IPQ-R
timeline) and Hypothesis 3 (IPQ-R Personal Control) were re-run post hoc with the
addition of extraversion and agreeableness, respectively. The regression analysis
predicting timeline therefore included the following predictors: BDI, neuroticism,
duration of longest depressive episode, and extraversion. In the full model, the original
results remained unchanged; extraversion was not significantly related to timeline and
neuroticism was the only significant predictor of timeline. The post hoc regression
analysis predicting personal control included BDI, neuroticism conscientiousness, and
agreeableness. In the original analysis, no predictors were significant in the full model. In
the post hoc analysis, agreeableness was significantly positively related to personal
control in the full model (p < .01).
Relationships between IPQ-R scales and depression history variables. The
following depression history variables were examined with respect to their correlations
with IPQ-R scales: history of depressive episode, history of past treatment for depression,
number of previous episodes and duration of the longest episode. Duration of the longest
depressive episode was significantly negatively correlated with personal control (r = -.22,
p < .05). No other indices of depression history were related to illness perceptions.
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Discussion
This study is the first to examine illness perceptions in patients with comorbid
depression and heart disease. The primary aim of the study was to examine baseline
relationships between patients’ perceptions of depression and depression severity,
personality, and depression history. A priori predictions were made regarding correlates
of consequences, timeline, personal control, and treatment control. It was predicted that
depression severity, neuroticism, and number of depressive episodes would be
significantly associated with consequences in multiple regression. Consequences were
strongly related to depression, but were not further explained by neuroticism or
depressive episodes. Exploratory analyses examined bivariate relationships between
consequences and personality, mood, and depression history. Notably, although it was
not a significant predictor in the multivariate model, neuroticism was significantly
correlated with consequences at the bivariate level. Since depression and neuroticism
were significantly correlated with each other, when both variables were in the regression
model,

depression

was

revealed

as

a

stronger

predictor

of

consequences.

Conscientiousness and anxiety were also positively related to consequences at the
bivariate level. Taken together, these results suggest that cardiac patients’ perceptions of
the consequences of their depression are strongly influenced by negative affect, and are
more strongly related to state (e.g., depression) than trait factors. Additionally, having
had more depressive episodes does not lead patients to expect more serious consequences
of their depression.
Although depression, neuroticism, and duration of the longest depressive episode
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were all hypothesized predictors of timeline perceptions, neuroticism was the only
significant predictor in the multivariate model. Indeed, depression was significant until
neuroticism was added to the model, indicating that the latter demonstrates stronger
explanatory power. Exploratory analyses also suggest that individuals who are higher on
extraversion perceive a shorter timeline for their depression. To determine whether
extraversion, or positive affect, could account for these findings, a post hoc analysis was
conducted including the original predictors and extraversion. The original results
remained unchanged, with neuroticism remaining the only significant predictor of
timeline. Interestingly, a significant interaction was found between duration of longest
depressive episode and neuroticism, demonstrating that the relationship between
neuroticism and timeline was stronger for individuals with shorter previous episodes of
depression, compared to individuals with longer previous episodes. It may be that, for
individuals who have less experience with depression (e.g., shorter episodes), perceived
length of current depression is influenced strongly by personality tendencies. However, in
individuals with longer past episodes, neuroticism is not as influential in determining
perceived timeline.
Contrary to the a priori prediction, none of the variables were significant in the
multiple regression model for personal control. Neuroticism was significantly inversely
related to personal control at the bivariate level. Exploratory analyses also revealed that
patients who were more agreeable endorsed more perceived personal control. This again
suggests an influence of personality factors on patients’ perceptions. Post hoc regression
analyses revealed that when agreeableness is added as a predictor to the original set of
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variables, it accounted for 5.6% of the variance in personal control (p < .05), and was the
only significant predictor in the model. It was not predicted that agreeableness would be
related to personal control, and an explanation for this finding was not readily available
in the literature. There is some evidence that agreeableness is related to more active
coping (e.g., Lawson, Bundy, Belcher, & Harvey, 2010), and personal control is also
related to active coping. Additionally, individuals who are high on agreeableness are
likely to foster more social support from others, and such support may lead one to feel a
greater sense of self-efficacy to manage depression.
Regression analyses predicting treatment control showed that while neuroticism
was significantly inversely related to treatment control, depression and number of
depressive episodes showed no relationship. Additionally, neuroticism was the only
variable that was significantly correlated with treatment control in exploratory bivariate
correlations. It is notable that depression severity showed no relationship (in multivariate
or bivariate analyses) to patients’ perception of the controllability of their depression.
Rather, control perceptions appear to be more strongly related to personality variables.
A priori predictions about the correlations among the IPQ-R scales were
supported by the data in three out of five cases. As expected, greater perceived
consequences were related to a longer perceived timeline, and both perceived treatment
control and personal control were associated with the perception of a shorter illness
timeline. However, there was no significant relationship between perceived treatment
control and consequences, or between personal control and consequences, even though
these are relationships that have been found in many previous studies across different
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patient samples (e.g., Hagger & Orbell, 2003). Although not predicted a priori, treatment
control and personal control were strongly correlated, which makes conceptual sense.
The emotional representations scale was significantly correlated with consequences and
timeline in post hoc analyses. The two scales that were most strongly related were
consequences and emotional representation, and each of these scales showed significant
positive correlations with the same four variables: depression, anxiety, neuroticism, and
conscientiousness. This raises the question of whether there is actually too much overlap
in the constructs measured by these two scales. Indeed, previous factor analytic studies in
other populations have demonstrated that the consequences and emotional representations
items consistently loaded onto one factor (Wittkowski et al., 2008).
A main goal of this study was to determine whether cardiac patients’ perceptions
of depression reflect more than just the severity of their depressive disorder. Personality
and/or depression history were therefore expected to relate to illness perceptions
independently of depression severity, and correlations between BDI and illness
perceptions were expected to be modest. The regression findings for the timeline,
personal control, and treatment control perceptions support the above hypothesis. Only
the consequences and emotional representation scales related particularly strongly to the
BDI in exploratory analyses (both p < .001). In the regression analysis of consequences,
other hypothesized predictors did not relate to consequences independently of depression.
Therefore, it cannot be ruled out that, among cardiac patients with depression,
perceptions of consequences represent little more than patients’ current depressive
severity, or are influenced by the depressive state. Indeed, it is reasonable to expect that
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patients would base their perceptions of the consequences of their depression on the
severity of symptoms they are currently experiencing. However, in order for this scale to
be helpful for understanding depression outcomes in heart patients, it should demonstrate
predictive utility above and beyond that of depression severity. It remains to be seen if
the consequences scale will be useful in this capacity; however, this will be examined in
future work.
The study did not confirm that the consequences scale related to other variables as
expected based on theory and previous research. Previously well-replicated associations
between consequences and other IPQ-R scales were also not found. These results raise
some concern about the application of the consequences scale to patients with comorbid
depression and heart disease. It is possible that the scale is approached differently by this
patient population. A confirmatory factor analysis could be conducted in the future to
determine if the 7 subscale model used by the IPQ-R fits well with data from the current
sample. This may be possible once a larger sample of data is accrued, as data collection is
ongoing. It may also be interesting to collect IPQ-R data from a depressed, otherwise
healthy sample and use confirmatory factor analytic techniques to compare the best
fitting subscale models between these two samples. This would help clarify if there is
something different about the dimensions that cardiac patients consider when
conceptualizing their depression, compared to medically healthy patients with depression.
Contrary to a priori predictions, the depression history variables were not
associated with illness perceptions, even though similar variables have been related to
perceptions of depression in other research (Brown et al., 2001). The most notable
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finding for depression history emerged as an interaction between neuroticism and
duration of longest past episode in the IPQ-R timeline analysis. It could be that past
experience with depression influences perceptions of current depression in complex
ways, such as through interactions with personality characteristics, and that more
complex analyses are needed to uncover the effects of depression history on perceptions
of depression. Alternatively, patients may not have been able to precisely recall the
answers to questions about their history of depression in the current study. For example,
patients were asked how many depressive episodes they had had as well as the duration
of the longest episode. Many patients reported a history of depression spanning years or
even decades, and may therefore have had difficulty with accurate recall of these details.
In other words, the current study’s assessment of past experience with depression may
represent an unreliable measure. A more precise measure could be obtained through
longitudinal follow-up of patients, or by verifying facts about patients’ past depression
through chart review. However, a longitudinal study of this kind would need to be
conducted over a very long period of time and would be extremely costly. Chart review
would present its own logistical problems, as this data may not be readily available in
medical records for many patients. Although the CSM posits that patients’ experience
with an illness influences their conceptualization of that illness, it is also possible that
depression history does not play a major role in the conceptualization of comorbid
depression among patients with heart disease. For instance, if patients truly have poor
recall for the details of their past depressive episodes (particularly those that occurred in
the remote past), their memories may not have an impact on their perceptions about their
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current episode.
In many cases, IPQ-R scales showed stronger relationships with personality
variables than with current depressive state. Previous work has not looked extensively at
the relationship between personality and illness perceptions, but several studies have
found a correlation between personality and subjective perceptions of overall health. The
Common Sense Model specifies that individuals’ illness perceptions are influenced by
several factors, including personality, so the current study’s findings fit within the CSM
framework. Additionally, this study replicated findings by Goetzmann et al. (2005) that
perceptions of control are negatively correlated with neuroticism. However, the fact that
perceptions related strongly to indices of personality traits, which are thought to be more
stable than mood, raises the question of whether illness perceptions in this population are
less dynamic than the CSM would specify. The CSM states that patients’ illness
perceptions change with experience and with the acquisition of new information.
Previous work has also found that patients’ beliefs about an illness are amenable to
change through intervention. This is particularly important because perceptions of control
may be promising as a focus for treatment, as they have been associated with adaptive
coping, and have predicted depression treatment outcomes (Glattacker et al., 2012). It is
possible that patients with comorbid depression and heart disease may differ from
previously studied populations in that they have more stable perceptions which are based
more strongly on personality factors. An alternative explanation is that patients form
beliefs about depression based upon their own personality tendencies in the absence of
objective information or efforts to change such beliefs. Preliminary evidence for this
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notion emerged in the significant interactive relationship found between neuroticism and
duration of longest episode on IPQ-R timeline. For individuals who had shorter
depressive episodes (and therefore had less information about depression), the effect of
neuroticism on timeline was large (r = .59). However, for patients with longer episodes,
the effect of neuroticism was relatively small (r = .12). Future work is needed to clarify
the potentially complex interactive effects between personality, depression history, and
perceptions of depression.
Several of the study’s findings did not fit with predictions based on the Common
Sense Model of Illness Perceptions. Specifically, perceptions of depression did not
reliably relate to past experience with depression. The consequences scale did not show
predicted relationships with other variables and may have been influenced by depression
state. Finally, perceptions of depression’s consequences did not relate to perceptions of
control, as has been established in many previous studies. Illness perceptions for
depression in patients with heart disease may behave somewhat differently than illness
perceptions in other illnesses or in medically healthy individuals with depression. There
could be several possible explanations for this. The current examination of illness
perceptions was conducted in the context of a treatment trial, which differs from the
context in which previous research has been conducted. Additionally, there may be
complex ways in which patients’ experience of heart disease influences their perceptions
of depression. This could be examined in several ways. First, patients’ perceptions of
both their heart disease and their depression could be measured, and relationships
between these two sets of perceptions could be investigated. Additionally, it would be
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useful to compare perceptions of depression in matched samples of medically healthy
patients and patients with cardiac disease. This is the first study to look at patient’s
perceptions of comorbid depression in a sample that has significant medical illness, and
future work should help clarify how this comorbidity may affect patient perceptions.
The study has several limitations. First, for the sake of project feasibility,
relationships were only examined among variables collected at baseline and the first
intervention session. However, longitudinal data for this study are currently being
collected and will be available in the future. Second, in order to minimize participant
burden, measures of coping were not collected. Given results from other research, it will
be important to examine relationships among illness perceptions and coping strategies in
this population. Additionally, the Big Five personality factors were assessed, but the
facets that make up these traits were not. Data on the relationship of personality facets to
illness perceptions may help explain what is driving the observed associations. Lastly,
coefficient alpha values observed in this sample indicated that the Mini-IPIP may not
have been reliable. In particular, the alpha for the neuroticism scale was quite low (.49),
suggesting that larger effects might have been observed with a more reliable measure. If
possible, future work should make use of a personality measure with more items per trait.
Data collection has continued since analysis of the data reported here, allowing
several of the above questions to be examined in future work. Additionally, hypotheses
pertaining to the process and outcome of treatment represent future research questions
that will be addressed using data collected as part of this study. Various measures of the
treatment process are being collected, including patients’ adherence to homework and
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number of intervention sessions attended. Initially, data will be examined to determine if
illness perceptions relate to depression treatment outcomes. IPQ-R scores before and
after undergoing CBT for depression will be examined to determine if patients’
perceptions of their depression change over time, and whether any changes correspond to
changes in depression severity. Future work will also examine how illness perceptions
relate to markers of treatment adherence such as adherence to CBT homework and
attendance of therapy sessions. If illness perceptions do impact treatment outcomes via
mediating factors such as adherence, interventions akin to those used in previous research
may be able to modify important illness beliefs. This line of work will contribute to our
knowledge of how individual difference characteristics relate to treatment in patients with
comorbid depression and heart disease, and may be used to develop more refined or
individually-tailored treatments.
Finally, illness perceptions may also be related to coping and treatment outcomes
in more complex ways than have been studied thus far. The impact of one illness
perception dimension on coping might be moderated by higher or lower scores on a
different dimension. For instance, patients with high scores on illness consequences but
also high scores on personal control may cope differently than patients with high
consequences but low personal control perceptions. However, no previous studies have
examined interactions between illness perceptions. This should be a goal of future work.
In summary, this study represents an important first step in elucidating how
patients with cardiac disease conceptualize comorbid depression, and the role that illness
perceptions may play in depression treatment among patients with heart disease. The
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results show that most dimensions of illness perceptions (with the exception of
consequences) are not influenced by depression, and in most cases relate to one another
in ways that are consistent with previous research findings. This suggests that assessment
of illness perceptions can increase our understanding of depression in heart patients, and
that illness perceptions represent individual differences which may inform treatment.
Finally, illness perceptions showed strong relationships with personality variables, which
has not been consistently studied and suggests an area where much future work is needed.
Data currently being collected for this study will be used in the future to investigate
important questions about the role of illness perceptions in the treatment of depression
among patients with heart disease.
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Table 1
Coefficient Alpha
Alpha
IPQ-R
Consequences
Timeline
Personal Control
Treatment Control
Emotional Representations
Illness Coherence
Timeline Cyclical
Mini-IPIP
Extroversion
Neuroticism
Agreeableness
Conscientiousness
Openness
BDI

.75
.76
.76
.78
.71
.82
.57
.67
.49
.63
.64
.65
.82
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Table 2
Demographic and Medical Characteristics
Total sample
(N = 112)
Characteristic
M (SD)
Age
59 (10.3)
Body mass index (kg/m2)
33 (6.9)
(n) %
Gender (% Female)
45 (40)
Caucasian
88 (79)
Education > 12 years
81 (72)
Cigarette smoker (current)
25 (22)
History of heart failure
45 (40)
History of MI
58 (52)
History of PTCA
64 (57)
History of CABG
30 (27)
History of CVA
11 (10)
History of hypertension
85 (76)
History of hyperlipidemia
89 (80)
History of diabetes mellitus
46 (41)
New York Heart Association
(NYHA)
Class I
2 (2)
Class II
33 (30)
Class III
13 (12)
Class IV
0
Missing
64 (57)
Note. MI = myocardial infarction; PTCA = percutaneous
transluminal coronary angioplasty; CABG = coronary artery
bypass grafting; CVA = cerebrovascular accident.

81

Table 3
Psychological Variables
Total sample
(N = 112)
M (SD)
30.4 (8)
15.5 (9.5)

Characteristic
BDI-II at baseline
BAI at baseline
IPQ-R
Consequences
22.7 (3.7)
Emotional Representation
21.4 (3.6)
Illness Coherence
14.3 (4.1)
Personal Control
22.0 (3.6)
Timeline
18.9 (4.0)
Treatment Control
18.1 (2.6)
Treatment Cyclical
13.55 (2.6)
Mini-IPIP
Agreeableness
14.4 (3.1)
Conscientiousness
11.9 (2.2)
Extroversion
10.2 (3.6)
Neuroticism
14.8 (3.0)
Openness
13.2 (3.3)
DISH Depression History
History of depressive episode [(n) %]
91 (81)
History of treatment of depression [(n) %]
80 (71)
Number of previous episodes
2.7 (2.7)
Duration of longest depressive episode (weeks)
81 (123)
Length of depression history (years)
15.7 (16)
Note. BDI-II = Beck Depression Inventory; BAI = Beck Anxiety
Inventory; IPQ-R = Illness Perception Questionnaire, Revised;
Mini-IPIP = International Personality Item Pool, short form; DISH =
Depression Interview and Structured Hamilton.
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Table 4
Predictors of IPQ-R Consequences
Predictor variables

Consequences

∆R2
Step 1
.15***
BDI-II
Step 2
.02
BDI-II
Neuroticism
.02
Step 3
BDI-II
Neuroticism
Number of previous episodes
.19
Model R2
Note. *p < .05, **p < .01, ***p < .001.
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β
.38***
.31**
.17
.31**
.16
-.15

Table 5
Predictors of IPQ-R Timeline
Predictor variables

Timeline
2

∆R
Step 1
BDI-II
Step 2
BDI-II
Neuroticism
Step 3
BDI-II
Neuroticism
Duration of longest episode
Model R2
Note. *p < .05, **p < .01, ***p < .001.

β

.06*
.24*
.10**
.09
.35**
.01
.08
.34**
.11
.17
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Table 6
Predictors of IPQ-R Personal Control
Predictor variables
Step 1
BDI-II
Step 2
BDI-II
Neuroticism
Step 3
BDI-II
Neuroticism
Conscientiousness
Model R2
Note. *p < .05, **p < .01, ***p < .001.

Personal Control
∆R2
β
.005
-.07
.033
.02
-.20
.001
.015
-.21
.03
.04
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Table 7
Predictors of IPQ-R Treatment Control
Predictor variables
Step 1
BDI-II
Step 2
BDI-II
Neuroticism
Step 3
BDI-II
Neuroticism
Past treatment for depression
Model R2
Note. *p < .05, **p < .01, ***p < .001.

Treatment Control
∆R2
β
.00
.02
.06**
.14
-.28**
.01
.15
-.28**
-.09
.07
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Table 8
Bivariate Correlations Between IPQ-R Scales
1
2
1. Consequences
2. Timeline
.26**
3. Personal Control
.04
-.47***
4. Treatment Control
.04-.01 -.41***
5. Emotional
.58***
.32**
Representation
6. Illness Coherence
-.03
.13
7. Timeline Cyclical
-.03
-.12
Note. *p < .05, **p < .01, ***p < .001.
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3

.57***
-.08
-.07
-.07

4

5

6

-.12
-.01

-.13

.01
-.14
-.08

Table 9
Correlations Between IPQ-R Scales and Mood
BDI-II
Consequences
.38***
Timeline
.24*
Personal Control
-.07
Treatment Control
.02
Emotional Representations
.53***
Illness Coherence
-.01
Timeline Cyclical
-.08
Note. *p < .05, **p < .01, ***p < .001.
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BAI
.18
.11
-.03
.15
.37***
-.05
.08

Table 10
Correlations Between IPQ-R Scales and Personality
Mini-IPIP
N
C
A
E
O
Consequences
.30**
-.22*
.04
-.04
.04
Timeline
.39***
-.15
-.09
-.25**
-.13
Personal Control
-.20*
.23*
.26**
.02
.08
Treatment Control
-.22*
.19*
.15
.02
.12
Emotional Representations
.49***
-.35***
-.12
-.13
-.19*
Illness Coherence
-.08
.03
.12
.15
.33***
Timeline Cyclical
.05
.05
-.09
.16
-.05
Note. N = Neuroticism; C = Conscientiousness; A = Agreeableness; E= Extroversion; O
= Openness
*p < .05, **p < .01, ***p < .001.
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Table 11
Correlations Between IPQ-R Scales and Depression History Variables
DISH Depression History
# of Previous
Duration of
Previous treatment
Episodes
longest episode
of depression
Consequences
-.15
-.05
.05
Timeline
-.04
.17
.11
Personal Control
-.01
-.22*
.04
Treatment Control
-.11
-.11
-.08
Emotional Representations
-.07
-.02
-.04
Illness Coherence
.10
.10
.05
Timeline Cyclical
.05
.05
-.05
Note. *p < .05, **p < .01, ***p < .001.
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Figure 1. Scatter plot of significant interaction in Hypothesis 2. Duration_Group =
Duration of longest depressive episode; Group 1 = short duration ( < 6 months), group 2
= medium duration ( > 6 months but < 2 years), group 3= long duration ( > 2 years).
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